Drawing for INFUSITE

USPTO serial 79200859

INFUSITE

Reviewed by CopyMark Law Group

Reg. 5357110Status 709
Filing date
Status date
Registration date
Dec 19, 2017
Examiner
PARKS, KIMBERLY L
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with INFUSITE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Laura L. Beoglos

Joseph A. Sebolt SAND & SEBOLT4940 Munson Street NWAegis Tower, Suite 1100Canton, OH 44718-3615

Goods and services

ClassDescriptionStatusFirst use
010Valves for use in medical infusion instruments; subcutaneous valves comprised of artificial materials for implantation; hypodermic needles for use in infusion therapy; medical and veterinary apparatus and instruments namely, for infusion, transfusion, drawing blood, measuring blood pressure, providing enteral and oral nutrition, and for surgical procedures in the fields of urology, incontinence, neonatology and pediatrics; medical and veterinary apparatus and instruments, namely, infusion sets, transfusion sets, extension tube lines and manifold connectors for the delivery of fluids for medical purposes, catheters, medical valves for controlling the flow of fluids through infusion tubing, infusion spikes in the nature of specialized needles for intravenous infusion, infusion lines in the nature of tubing for the delivery of intravenous and orally administered fluids, drip chambers to allow gas to rise out of intravenous fluids so that it is not passed downstream; medical and veterinary apparatus and instruments, namely, special sets for preparation and administration of total intravenous anesthesia (tiva) with said sets being comprised primarily of syringes sold empty, syringe pumps, medical valves for controlling the flow of fluids through infusion tubes, infusion lines and manifold connections for the delivery of fluids for medical purposes, drip chambers to allow gas to rise out of intravenous fluids so that it is not passed downstream, infusion spikes in the nature of specialized needles for intravenous infusion, intravenous (i.v.) filters and/or filter systems comprised of particular matter traps to isolate foreign matter while allowing infusion fluids to pass into a patient's system; medical and veterinary apparatus and instruments, namely, special sets for preparation and administration of cytotoxic drugs, with said sets being comprised primarily of extension tube lines and manifold connectors for the delivery of fluids for medical purposes, intravenous (i.v.) filters and filter systems comprised of particular matter traps to isolate foreign matter while allowing infusion fluids to pass into a patient's system, medical valves for controlling the flow of fluids through infusion tubes, infusion spikes in the nature of specialized needles for intravenous infusion, infusion lines in the nature of tubing for the delivery of intravenous and orally administered fluids, drip chambers to allow gas to rise out of intravenous fluids so that it is not passed downstream, cannulas, syringes sold empty; medical and veterinary apparatus and instruments, namely, preparation sets for preparation of drugs comprised primarily of extension lines and manifold connectors for the delivery of fluids for medical purposes, intravenous (i.v.) filters and filter systems comprised of particular matter traps to isolate foreign matter while allowing infusion fluids to pass into a patient's system, medical valves for controlling the flow of fluids through infusion tubing, infusion spikes in the nature of specialized needles of intravenous infusion, infusion lines in the nature of tubing for the delivery of intravenous and orally administered fluid, drip chambers to allow gas to rise out of intravenous fluids so that it is not passed downstream, cannulas, syringes sold empty; medical and veterinary apparatus and instruments, namely, administration sets for administration of drugs and liquids, with said sets being comprised primarily of burettes, extension lines and manifold connectors for the delivery of fluid for medical purposes, intravenous (i.v.) filters and filter systems comprised of particular matter traps to isolate foreign matter while allowing infusion fluids to pass into a patient's system, medical valves for controlling the flow of fluids through infusion tubing, infusion spikes in the nature of specialized needles for intravenous infusion, infusion lines in the nature of tubing for the delivery of intravenous and orally administered fluids, drip chambers to allow gas to rise out of intravenous fluids so that it is not passed downstream, medical tubing for the withdrawal of blood, syringes sold empty and cannulas; medical infusion pumps; intravenous infusion pumps for medical purposes; infusion pumps to deliver medication; infusion pumps for medical purposes; injection syringes; infusion apparatus for therapeutic purposes; surgical and wound treating equipment, namely, drainage adapterSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 6, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB—
May 22, 2025INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
May 22, 2025INPCINVALIDATION PROCESSED—
Mar 5, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 9, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 5, 2024C71TCANCELLED SECTION 71—
May 13, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Dec 19, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 11, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 29, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 28, 2018FIMPFINAL DISPOSITION PROCESSED—
Mar 19, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 19, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 3, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 3, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 13, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 22, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 16, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 15, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 15, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 15, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 3, 2017RFNPREFUSAL PROCESSED BY IB—
Feb 16, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 16, 2017RFRRREFUSAL PROCESSED BY MPU—
Feb 15, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 14, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 11, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 7, 2017DOCKASSIGNED TO EXAMINER—
Feb 7, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 2, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance